C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 295/18 (2006.01) A61K 31/166 (2006.01) A61K 31/40 (2006.01) A61K 31/4453 (2006.01) A61K 31/4535 (2006.01) A61P 3/04 (2006.01) A61P 25/02 (2006.01) A61P 25/08 (2006.01) A61P 25/22 (2006.01) C07C 233/65 (2006.01) C07D 211/46 (2006.01) C07D 333/20 (2006.01) C07D 333/38 (2006.01)
Patent
CA 2536461
The invention provides novel GlyT2 inhibiting compounds useful in modulating, treating, or preventing: anxiolytic disorders; a condition requiring treatment of injured mammalian nerve tissue; a condition amenable to treatment through administration of a neurotrophic factor; a neurological disorder; or obesity; an obesity-related disorder.
L'invention concerne de nouveaux composés inhibiteurs de GlyT2 qui permettent de moduler, de traiter ou de prévenir des troubles dus aux anxiolytiques ; une affection exigeant un traitement d'un tissu nerveux mammalien blessé ; une affection pouvant faire l'objet d'un traitement par administration d'un facteur neurotrophique ; un trouble neurologique ; l'obésité ; un trouble associé à l'obésité.
Huang Charles Q.
Lovenberg Timothy W.
Santillan Alejandro Jr.
Tang Liu Y.
Wolin Ronald L.
Janssen Pharmaceutica N.v.
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
LandOfFree
Aryl piperidine amides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl piperidine amides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl piperidine amides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1861714